Treatment

Roflumilast foam 0.3%, a non-steroidal PDE4 inhibitor, has shown significant promise for treating psoriasis in adults and adolescents aged 12 and older....
CURATED BY: Alison Kortz,
PA-C

A Once-Daily Patch for Psoriasis

Researchers at the University of Copenhagen have developed a patch designed to make psoriasis treatment easier and more effective....
CURATED BY:
Alison Kortz,
PA-C

Bimekizumab Shows Low Risk of Suicidal Ideation and Depression in Psoriasis Patients

Patients with psoriasis have an increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, an interleukin (IL)-17A and...
CURATED BY:
Renee Ott,
MSN, CNP

Study Highlights Psoriasis in Special Body Areas and Increased Use of Biologics With Multiple Areas Involved

Researchers of a recent study examined psoriasis in special body areas, such as the scalp, palmoplantar, genitals, and nails. The...
CURATED BY:
Alison Kortz,
PA-C

Managing Psoriasis in Older Patients: Balancing Treatment Efficacy and Increased Risks

Psoriasis treatments for patients of all ages often include topicals, phototherapy, oral agents like methotrexate and cyclosporine, new oral inhibitors,...
CURATED BY:
Renee Ott,
MSN, CNP

LITE Study Shows Home-Based Phototherapy Effective for Psoriasis, Boosts Treatment Adherence

Researchers of the LITE Study demonstrated that home-based phototherapy for psoriasis is non-inferior to office-based phototherapy across all skin types...
CURATED BY:
Renee Ott,
MSN, CNP

Review Highlights Promising Efficacy of JAK Inhibitors in Treating Psoriasis and Psoriatic Arthritis

Psoriasis often involves joint symptoms known as psoriatic arthritis (PsA) in about 20% of cases. Effective treatments must target both...
CURATED BY:
Leigh Ann Pansch,
MSN, FNP-BC, DCNP
Share